1
|
A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
|
N Engl J Med
|
2002
|
5.58
|
2
|
Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.
|
J Invest Dermatol
|
2007
|
3.58
|
3
|
Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
|
J Am Acad Dermatol
|
2007
|
2.71
|
4
|
Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
|
Arch Dermatol
|
2002
|
2.49
|
5
|
A single cycle of rituximab for the treatment of severe pemphigus.
|
N Engl J Med
|
2007
|
2.41
|
6
|
Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.
|
J Allergy Clin Immunol
|
2004
|
2.33
|
7
|
Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression.
|
Arch Dermatol
|
2003
|
1.94
|
8
|
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs.
|
Pharmacogenet Genomics
|
2008
|
1.92
|
9
|
Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
|
Arch Dermatol
|
2009
|
1.66
|
10
|
Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals.
|
J Hepatol
|
2011
|
1.60
|
11
|
Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis.
|
Pediatrics
|
2009
|
1.53
|
12
|
Differential diagnosis of severe cutaneous drug eruptions.
|
Am J Clin Dermatol
|
2003
|
1.53
|
13
|
Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome.
|
Dermatol Online J
|
2002
|
1.35
|
14
|
Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist?
|
Orphanet J Rare Dis
|
2012
|
1.32
|
15
|
Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis.
|
J Invest Dermatol
|
2002
|
1.32
|
16
|
Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
|
J Invest Dermatol
|
2013
|
1.28
|
17
|
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.
|
J Invest Dermatol
|
2009
|
1.26
|
18
|
Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.
|
J Invest Dermatol
|
2010
|
1.22
|
19
|
Response to: mortality rate of bullous pemphigoid in a US medical center.
|
J Invest Dermatol
|
2005
|
1.18
|
20
|
Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.
|
Sci Transl Med
|
2013
|
1.15
|
21
|
Rare variations in IL36RN in severe adverse drug reactions manifesting as acute generalized exanthematous pustulosis.
|
J Invest Dermatol
|
2013
|
1.12
|
22
|
French people and skin diseases: results of a survey using a representative sample.
|
Arch Dermatol
|
2003
|
1.11
|
23
|
Evaluation of the potential role of cytokines in toxic epidermal necrolysis.
|
J Invest Dermatol
|
2004
|
1.09
|
24
|
Drug hypersensitivity: pharmacogenetics and clinical syndromes.
|
J Allergy Clin Immunol
|
2011
|
1.07
|
25
|
Drug-induced skin, nail and hair disorders.
|
Drug Saf
|
2007
|
1.07
|
26
|
Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis.
|
J Invest Dermatol
|
2006
|
1.04
|
27
|
Treatment of epidermal necrolysis with high-dose intravenous immunoglobulins (IV Ig): clinical experience to date.
|
Drugs
|
2005
|
1.02
|
28
|
Soluble interleukin 2 receptor and interleukin 1alpha in toxic epidermal necrolysis: a comparative analysis of serum and blister fluid samples.
|
Arch Dermatol
|
2002
|
0.99
|
29
|
In vivo confocal microscopic evaluation of corneal changes in chronic Stevens-Johnson syndrome and toxic epidermal necrolysis.
|
Cornea
|
2009
|
0.98
|
30
|
Acute bacterial skin infections and cellulitis.
|
Curr Opin Infect Dis
|
2007
|
0.96
|
31
|
Impact of STROBE statement publication on quality of observational study reporting: interrupted time series versus before-after analysis.
|
PLoS One
|
2013
|
0.95
|
32
|
A three-year-analysis of fixed drug eruptions in hospital settings in France.
|
Eur J Dermatol
|
2010
|
0.93
|
33
|
Genome-wide association study of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Europe.
|
Orphanet J Rare Dis
|
2011
|
0.91
|
34
|
Efalizumab-induced bullous pemphigoid.
|
J Am Acad Dermatol
|
2010
|
0.88
|
35
|
Prospective evaluation of risk factors of cutaneous drug reactions to sulfonamides in patients with AIDS.
|
J Am Acad Dermatol
|
2002
|
0.86
|
36
|
Pemphigus vulgaris: a case-based update.
|
J Can Dent Assoc
|
2005
|
0.85
|
37
|
Successful treatment of nodular lymphangitis due to Mycobacterium chelonae in two immunosuppressed patients.
|
Dermatol Online J
|
2011
|
0.84
|
38
|
Recurrent erythema multiforme in association with recurrent Mycoplasma pneumoniae infections.
|
J Am Acad Dermatol
|
2007
|
0.84
|
39
|
Association analysis of drug metabolizing enzyme gene polymorphisms in AIDS patients with cutaneous reactions to sulfonamides.
|
J Invest Dermatol
|
2005
|
0.82
|
40
|
Chronic granulomatous Mycobacterium avium skin pseudotumour.
|
Lancet Infect Dis
|
2009
|
0.82
|
41
|
Atypical linear IgA dermatosis revealing angioimmunoblastic T-cell lymphoma.
|
Arch Dermatol
|
2009
|
0.81
|
42
|
Death ligand TRAIL, secreted by CD1a+ and CD14+ cells in blister fluids, is involved in killing keratinocytes in toxic epidermal necrolysis.
|
Exp Dermatol
|
2011
|
0.81
|
43
|
Evaluation of SCORTEN on a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study.
|
J Burn Care Res
|
2011
|
0.81
|
44
|
Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures.
|
Medicine (Baltimore)
|
2010
|
0.80
|
45
|
Severe and unrecognized dental abnormalities after drug-induced epidermal necrolysis.
|
Arch Dermatol
|
2009
|
0.79
|
46
|
Stevens-Johnson syndrome/toxic epidermal necrolysis: are drug dictionaries correctly informing physicians regarding the risk?
|
Drug Saf
|
2013
|
0.79
|
47
|
Denominations and classification of severe cutaneous adverse reactions to drugs: splitters versus mergers.
|
Eur J Dermatol
|
2007
|
0.78
|
48
|
Neurological manifestations of polyarteritis nodosa associated with the antiphospholipid syndrome.
|
Ann Med Interne (Paris)
|
2003
|
0.77
|
49
|
Possible relation of Tunisian pemphigus with traditional cosmetics: a multicenter case-control study.
|
Am J Epidemiol
|
2002
|
0.77
|
50
|
Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study.
|
Arch Dermatol
|
2009
|
0.77
|
51
|
Treatment of bullous pemphigoid.
|
J Dermatol
|
2003
|
0.76
|
52
|
Vesiculopustules in adult-onset Still's disease.
|
J Am Acad Dermatol
|
2006
|
0.76
|
53
|
Drug-induced epidermal necrolysis: Important new piece to end the puzzle.
|
J Allergy Clin Immunol
|
2011
|
0.76
|
54
|
Minocycline-induced DRESS: evidence for accumulation of the culprit drug.
|
Dermatology
|
2008
|
0.76
|
55
|
Cell-mediated immunologic mechanism and severity of TEN.
|
Arch Dermatol
|
2005
|
0.75
|
56
|
[Use of high dose intravenous immunoglobulins in dermatology].
|
J Dtsch Dermatol Ges
|
2010
|
0.75
|
57
|
EMPACT syndrome.
|
J Dtsch Dermatol Ges
|
2005
|
0.75
|
58
|
Intravenous immunoglobulins in the treatment of severe drug eruptions.
|
Curr Opin Allergy Clin Immunol
|
2003
|
0.75
|
59
|
Prognostic value of histologic features of toxic epidermal necrolysis.
|
J Am Acad Dermatol
|
2011
|
0.75
|
60
|
Seasonal variation of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with trimethoprim-sulfamethoxazole.
|
J Am Acad Dermatol
|
2011
|
0.75
|
61
|
Nosocomial disseminated Mycobacterium chelonae infection in an immunocompromised patient.
|
Eur J Dermatol
|
2010
|
0.75
|
62
|
Septic facial vein thrombosis due to Panton-Valentine leukocidin-positive Staphylococcus aureus.
|
Arch Dermatol
|
2009
|
0.75
|
63
|
Terbinafine-induced subacute cutaneous lupus erythematosus.
|
Dermatology
|
2006
|
0.75
|
64
|
The role of topical corticosteroids in bullous pemphigoid in the elderly.
|
Drugs Aging
|
2005
|
0.75
|
65
|
Lack of a specific humoral autoreactivity in sera from patients with early erythema exsudativum multiforme majus.
|
J Invest Dermatol
|
2013
|
0.75
|
66
|
Severe sialadenitis: a new complication of drug reaction with eosinophilia and systemic symptoms.
|
J Am Acad Dermatol
|
2004
|
0.75
|
67
|
[Role of the nurse in care of bullous pemphigoid].
|
Rev Infirm
|
2010
|
0.75
|